Kai Health utilizes artificial intelligence to enhance embryo grading and optimize cryopreservation inventory management, enabling fertility clinics to make data-driven treatment decisions. This approach reduces the number of treatment cycles needed while improving the chances of successful outcomes for patients seeking to conceive.
Funding
Funding not disclosed
Founders
Product
Problem
In vitro fertilization (IVF) treatment decisions are often based on individual clinician experience, leading to variable outcomes. Traditional embryo grading and cryopreservation inventory management can be subjective and inefficient, potentially increasing the number of treatment cycles needed for successful conception.
Solution
Kai Health offers an AI-powered platform designed to enhance decision-making in fertility clinics. The platform, called Vita Hub, provides tools for standardized embryo grading using AI (Vita Embryo), optimized cryopreservation inventory management (Vita Cryo), and modernized IVF lab data management (Vita Note). By systematically gathering and analyzing data from diverse sources, Kai Health empowers clinicians to make more informed and personalized treatment decisions, potentially improving the chances of successful outcomes while reducing the number of cycles required.
Target Audience
Kai Health's primary customers are fertility clinics and IVF labs seeking to improve treatment outcomes and streamline operations through AI-powered data analysis and management.
Features
- Vita Embryo: AI-driven embryo grading for standardized and automated analysis.
- Vita Cryo: Integrated tracking and visualized control for optimized cryopreservation inventory management.
- Vita Note: Cloud-based IVF lab data management platform for seamless transition from paper records.
- AI-powered analysis of microscope and time-lapse images for embryo ranking.
- Support for clinicians in making data-driven decisions at every step of fertility treatment.